Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CLEAR: HTS and Carbocisteine in Bronchiectasis
NCT04140214Phase 3Completed
- Sponsor
- Belfast Health and Social Care Trust
- Start
- Jun 2018
- Primary completion
- Sep 2024
- Modality
- Small Molecules, Device-based Delivery
- Countries
- 1
01
Overview
A Phase 3 trial of hypertonic saline, carbocisteine in bronchiectasis, sponsored by Belfast Health and Social Care Trust. Started Jun 2018; status: completed.
02
Drugs
hypertonic salinecarbocisteine
03
Conditions
bronchiectasis
Beyond the preview
Go deeper on NCT04140214.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04140214.